Related Experiment Video

Updated: Aug 14, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

Bile duct adenomas in heterozygous (MZ) deficiency of alpha 1-protease inhibitor

P M Scheele1, M J Bonar, R Zumwalt

  • 1Department of Pathology, University of Cincinnati Medical Center, OH 45267.

Archives of Pathology & Laboratory Medicine
|September 1, 1988
PubMed

Insights

A rare case links bile duct adenomas to alpha 1-proteinase inhibitor (API) deficiency. Accumulation of API in adenomatous tissue suggests it may trigger neoplastic transformation in the bile ducts.

Area of Science:

  • Hepatology and Gastroenterology
  • Oncology
  • Genetics

Background:

  • Bile duct adenomas are rare benign tumors.
  • Alpha 1-proteinase inhibitor (API) deficiency is a genetic disorder linked to lung and liver disease.
  • The association between API deficiency and bile duct adenomas is not well-established.

Observation:

  • A case of bile duct adenomas was identified in a patient with heterozygous (MZ) alpha 1-proteinase inhibitor (API) deficiency.
  • Large API-containing globules were observed within the adenomatous tissue.
  • API was minimally present in hepatocytes and absent in bile ducts within the adenoma and surrounding liver parenchyma.

Findings:

  • Bile duct markers (cytokeratin, CEA) were present in adenomatous tissue and normal bile ducts, but not hepatocytes.
  • This suggests the adenomas originate from ductular structures, not liver cell metaplasia.
  • The localized accumulation of API within the adenoma is a key pathological finding.

Implications:

  • The study postulates that localized accumulation of alpha 1-proteinase inhibitor (API) may act as a trigger for neoplastic transformation in bile duct adenomas.
  • This finding could offer new insights into the pathogenesis of bile duct tumors in individuals with API deficiency.
  • Further research is warranted to explore the mechanistic link between API accumulation and bile duct neoplasia.

More Related Videos

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

Determining Bile Duct Density in the Mouse Liver07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...